Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer.
Saved in:
| Title: | Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer. |
|---|---|
| Authors: | Zhao JJ; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore., Fong KY; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore., Chan YH; Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore., Tey J; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore., Dawood S; Department of Medical Oncology, Mediclinic City Hospital, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai 505055, United Arab Emirates., Lee SC; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore.; Cancer Science Institute, National University of Singapore, Singapore 119074, Singapore., Finn RS; Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA 90024, USA., Sundar R; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore 169547, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore 117456, Singapore.; Singapore Gastric Cancer Consortium, Singapore 119074, Singapore., Lim JSJ; Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore.; Cancer Science Institute, National University of Singapore, Singapore 119074, Singapore. |
| Source: | Cancers [Cancers (Basel)] 2023 Sep 14; Vol. 15 (18). Date of Electronic Publication: 2023 Sep 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers15184558 |
